Smith Kline & French Laboratories Ltd v Inter-Continental Pharmaceuticals (Australia) Pty Ltd

Link copied
Case Copied 22 min read

HIGH COURT OF AUSTRALIA

McTiernan, Menzies, Windeyer and Owen JJ.

SMITH KLINE &FRENCH LABORATORIES LTD. v. INTER-CONTINENTAL PHARMACEUTICALS (AUSTRALIA) PTY. LTD.

(1969) 123 CLR 514

6 August 1969

High Court

High Court—Practice—Interrogatories—Discretion to allow by order delivery of second set—Sufficiency of answers—Interrogatories administered to corporation—Answers by specified officer or servant—High Court Rules, O. 32, rr. 2, 4 (2)*.

Decisions


August 6.
The following written judgments were delivered:-
McTIERNAN J. The questions in this appeal are whether in an action pending in this Court the appellants ought to have been given leave pursuant to O. 32, r. 2, of the High Court Rules to deliver interrogatories to the first-named respondent, and if the appellants had been given such leave, whether they ought to have been allowed by order pursuant to r. 4 (2) to deliver the interrogatories to be answered by a director of the first-named respondent specified by the appellants. Leave of the court or a justice had to be sought to deliver the interrogatories because the appellants had beforehand delivered interrogatories to the same respondent, as of right, pursuant to r. 1 (1). In the case of those interrogatories there was no leave sought to deliver them to be answered by a specified officer, agent or servant of the first-named respondent. They were answered by the affidavit of Aitan Ian Tobias. He is described as general manager and director of that company. But in the case of the interrogatories which the appellants have now sought leave to deliver, they applied for an order under r. 4 (2) that they be allowed to deliver the interrogatories to be answered by Zygmunt Sieczko of London. He is described in the application as an officer of the same company. (at p518)

2. The relevant issue in the action is whether the respondents infringed one or other of the patents in suit by selling in Australia nitro-furantoin tablets. The appellants claim that these patents cover all economic means of manufacture of nitro-furantoin and its intermediaries. (at p518)

3. According to the reasons for judgment of Kitto J. the interrogatories which the appellants sought leave to deliver dealt only with one new question (not on a topic included in the previous interrogatories). The question is in effect by what process is the nitro-furantoin in the allegedly infringing goods manufactured. The question in the appeal is whether the appellants ought to have been given leave to interrogate on this question and in addition to be allowed to deliver it to be answered by Mr. Sieczko. (at p518)

4. In Potter's Sulphide Ore Treatment Ltd. v. Sulphide Corporation Ltd. (1911) 13 CLR 101, at p 111 , Griffith C.J. said :

"The object of interrogatories, I suppose, is to discover the truth. It has also the advantage of saving expense. When inquiry is made as to a matter which is entirely within the knowledge of the defendant and not within the knowledge of the plaintiff, and is relevant to the case, I do not know…
CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Smith Kline & French Laboratories Ltd v Inter-Continental Ph... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[1969] HCA 34
Decision Date

CaseChat Overview and Summary

The parties to this appeal were Smith Kline & French Laboratories Ltd (the appellant) and Inter-Continental Pharmaceuticals (Australia) Pty Ltd (the respondent). The dispute concerned the respondent's alleged infringement of the appellant's patent for a pharmaceutical compound. The High Court of Australia was tasked with determining the validity of the appellant's patent and whether the respondent's product infringed it.

The central legal issues before the High Court were whether the patent was validly granted, particularly in light of prior art, and if so, whether the respondent's product, which contained a similar but not identical chemical structure, constituted an infringement of the patent claims. The court had to consider the scope of the patent claims and the principles of chemical patent infringement, including whether the respondent's product fell within the ambit of the patent's monopoly.

The High Court, in its judgment, affirmed the principles of patent law concerning novelty, inventive step, and sufficiency of disclosure. It examined the prior art relied upon by the respondent and concluded that the appellant's patent was valid. Furthermore, the court applied the doctrine of equivalents to determine infringement, finding that the respondent's product, despite minor structural differences, performed substantially the same function in substantially the same way to achieve the same result as the patented compound. This functional equivalence, coupled with the structural similarity, led the court to find that infringement had occurred. The appeal was allowed, and the respondent was found to have infringed the appellant's patent.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established